Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

Observational Study With Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00227240

Enrollment

753

Registered

2005-09-27

Start date

2005-04-30

Completion date

2009-06-30

Last updated

2012-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plaque Psoriasis

Brief summary

The purpose of this study is to investigate the incidences of adverse events for patients with plaque psoriasis treated with Enbrel under usual care settings.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Proven diagnosis of Plaque Psoriasis

Exclusion criteria

* Contraindications according to SmPC of Enbrel

Countries

Germany

Outcome results